DISEASE INDICATIONS: phenylketonuria (PKU)
MANUFACTURER: BioMarin Pharmaceutical Inc.
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Palynziq is a prescription medication that reduces phenylalanine levels in the blood by converting it to another amino acid for the treatment of Phenylketonuria (PKU).